The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 180.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.778%)
Open: 182.50
High: 182.50
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Mar 2016 16:20

RNS Number : 0089R
Synectics PLC
03 March 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SYNECTICS PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

02 MARCH 2016

6. Date on which issuer notified:

03 MARCH 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0007156838

523,500

523,500

1,184,000

1,184,000

6.6538%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

1,184,000

6.6538%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

1,150,000 of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis. The remaining shares are held for other discretionary clients.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

David Clueit

Hargreave Hale Ltd

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFLRVTIVIIR
Date   Source Headline
27th Nov 201811:29 amRNSDirector/PDMR Shareholding
29th Oct 201810:04 amRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirectorate Change
28th Aug 20187:00 amRNSSynectics secures UK custodial sites
14th Aug 20184:00 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSInterim Results
27th Jun 20187:00 amRNSNotification of Interim Results
1st Jun 20187:00 amRNSDirectorate Change
30th May 20183:23 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSContract Win
11th May 20183:38 pmRNSDirector/PDMR Shareholding
27th Apr 201811:42 amRNSDirector/PDMR Shareholding
26th Apr 20181:12 pmRNSResult of AGM
26th Apr 20187:00 amRNSAGM Statement
29th Mar 20182:09 pmRNSDirector/PDMR Shareholding
27th Mar 20184:52 pmRNSHolding(s) in Company
26th Mar 20187:00 amRNSContract Win
21st Mar 20187:01 amRNSAnnual Report and Notice of AGM
21st Mar 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSFinal Results
23rd Jan 20187:00 amRNSNotification of Final Results
8th Jan 20183:19 pmRNSElectronic Communication with Shareholders
4th Jan 20181:15 pmRNSHolding(s) in Company
13th Dec 20171:43 pmRNSHolding(s) in Company
12th Dec 20177:00 amRNSTrading Update
1st Dec 20175:35 pmRNSAIM Disclosure Update
30th Oct 20174:40 pmRNSDirector/PDMR Shareholding
16th Oct 20173:23 pmRNSDirector/PDMR Shareholding
22nd Sep 20173:02 pmRNSDirector/PDMR Shareholding
21st Sep 20173:58 pmRNSHolding(s) in Company
6th Sep 201710:01 amRNSDirector/PDMR Shareholding
29th Aug 20175:11 pmRNSHolding(s) in Company
18th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSNotification of Interim Results
6th Jun 20175:54 pmRNSRe-appointment of Auditor
26th May 201710:04 amRNSDirector/PDMR Shareholding
28th Apr 20174:01 pmRNSDirector/PDMR Shareholding
27th Apr 20171:08 pmRNSResult of AGM
27th Apr 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSContract Wins
24th Mar 20172:43 pmRNSPosting of Annual Report and AGM Notice
7th Mar 20179:55 amRNSDirector/PDMR Shareholding
2nd Mar 201711:32 amRNSDirector/PDMR Shareholding
21st Feb 20177:00 amRNSFinal Results
30th Jan 20177:00 amRNSNotification of Final Results
10th Jan 20177:00 amRNSAdoption of Financial Reporting Standard 101
8th Dec 20167:00 amRNSYear End Trading Update
21st Oct 20162:20 pmRNSDirector/PDMR Shareholding
19th Jul 20167:01 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.